Current Issues

	Access to Care and Therapies from Day 1 Early detection and intervention of neuromuscular diseases is critical in order to deliver adequate and appropriate healthcare. Continue reading →
	Accelerating Therapy Development We are committed to working with key stakeholders, including the US Food and Drug Administration (FDA), to help accelerate development of life-changing therapies. Continue reading →
	Empowerment and Independence MDA works every day to ensure that members of the neuromuscular community are able to learn, work, travel, and socialize without discrimination. Continue reading →
	COVID-19 Vaccine Tacker and Advocacy Resources Even during this pandemic, MDA won’t stop advocating for the neuromuscular disease community. Policies, regulations, and events on Capitol Hill are changing every day. Check out the latest on the COVID-19 vaccine, the federal government’s response to COVID-19, and how policies are affecting those with neuromuscular disease. Continue reading →
	MDA Advocacy Statements and Communications to Policy Makers Learn more about MDA's communication with policy makers. Continue reading →